RORA
Summary: The protein encoded by this gene is a member of the NR1 subfamily of nuclear hormone receptors. It can bind as a monomer or as a homodimer to hormone response elements upstream of several genes to enhance the expression of those genes. The encoded protein has been shown to interact with NM23-2, a nucleoside diphosphate kinase involved in organogenesis and differentiation, as well as with NM23-1, the product of a tumor metastasis suppressor candidate gene. Also, it has been shown to aid in the transcriptional regulation of some genes involved in circadian rhythm. Four transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Feb 2014].
Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
---|---|---|---|---|---|
RAR related orphan receptor A | MIM:600825 | Ensembl:ENSG00000069667 | HGNC:HGNC:10258 | PA34630 | 15q22.2 |
GO terms in RORA
Term Type | Evidence Type | GO Term ID | GO Des. |
---|---|---|---|
BP | IMP | GO:0001525 | angiogenesis |
BP | IDA | GO:0006355 | regulation of transcription, DNA-templated |
BP | TAS | GO:0006367 | transcription initiation from RNA polymerase II promoter |
BP | ISS | GO:0006805 | xenobiotic metabolic process |
BP | IEA | GO:0006809 | nitric oxide biosynthetic process |
BP | ISS | GO:0008589 | regulation of smoothened signaling pathway |
BP | IMP | GO:0010575 | positive regulation of vascular endothelial growth factor production |
BP | ISS | GO:0010906 | regulation of glucose metabolic process |
BP | ISS | GO:0019218 | regulation of steroid metabolic process |
BP | TAS | GO:0019221 | cytokine-mediated signaling pathway |
BP | IEA | GO:0021702 | cerebellar Purkinje cell differentiation |
BP | ISS | GO:0021930 | cerebellar granule cell precursor proliferation |
BP | IDA | GO:0030522 | intracellular receptor signaling pathway |
BP | ISS | GO:0032922 | circadian regulation of gene expression |
BP | IDA | GO:0036315 | cellular response to sterol |
BP | IMP | GO:0036315 | cellular response to sterol |
BP | ISS | GO:0042632 | cholesterol homeostasis |
BP | IMP | GO:0042692 | muscle cell differentiation |
BP | ISS | GO:0042753 | positive regulation of circadian rhythm |
BP | IEA | GO:0043030 | regulation of macrophage activation |
BP | IMP | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling |
BP | IEA | GO:0043401 | steroid hormone mediated signaling pathway |
BP | ISS | GO:0045599 | negative regulation of fat cell differentiation |
BP | IDA | GO:0045893 | positive regulation of transcription, DNA-templated |
BP | IDA | GO:0045944 | positive regulation of transcription by RNA polymerase II |
BP | IEA | GO:0046068 | cGMP metabolic process |
BP | IBA | GO:0050728 | negative regulation of inflammatory response |
BP | IMP | GO:0050728 | negative regulation of inflammatory response |
BP | ISS | GO:0060850 | regulation of transcription involved in cell fate commitment |
BP | IMP | GO:0070328 | triglyceride homeostasis |
BP | IEA | GO:0071347 | cellular response to interleukin-1 |
BP | IEA | GO:0071356 | cellular response to tumor necrosis factor |
BP | IMP | GO:0071456 | cellular response to hypoxia |
BP | ISS | GO:0072539 | T-helper 17 cell differentiation |
CC | IDA | GO:0005634 | nucleus |
CC | TAS | GO:0005654 | nucleoplasm |
MF | IDA | GO:0000977 | RNA polymerase II regulatory region sequence-specific DNA binding |
MF | IDA | GO:0000978 | RNA polymerase II proximal promoter sequence-specific DNA binding |
MF | ISA | GO:0000981 | RNA polymerase II transcription factor activity, sequence-specific DNA binding |
MF | ISM | GO:0000981 | RNA polymerase II transcription factor activity, sequence-specific DNA binding |
MF | NAS | GO:0000981 | RNA polymerase II transcription factor activity, sequence-specific DNA binding |
MF | IPI | GO:0001222 | transcription corepressor binding |
MF | IBA | GO:0001223 | transcription coactivator binding |
MF | IPI | GO:0001223 | transcription coactivator binding |
MF | IC | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding |
MF | IDA | GO:0003677 | DNA binding |
MF | IDA | GO:0003700 | DNA-binding transcription factor activity |
MF | IEA | GO:0003707 | steroid hormone receptor activity |
MF | IEA | GO:0004879 | nuclear receptor activity |
MF | IPI | GO:0005515 | protein binding |
MF | IEA | GO:0008013 | beta-catenin binding |
MF | IPI | GO:0008134 | transcription factor binding |
MF | IBA | GO:0008142 | oxysterol binding |
MF | IDA | GO:0008142 | oxysterol binding |
MF | IEA | GO:0008270 | zinc ion binding |
MF | IDA | GO:0043565 | sequence-specific DNA binding |
MF | IDA | GO:0098531 | transcription factor activity, direct ligand regulated sequence-specific DNA binding |
Gene expression in normal tissue: RORA
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in RORA
Database | Pathway ID | Pathway Des. |
---|---|---|
pid | hif1_tfpathway | HIF-1-alpha transcription factor network |
kegg | hsa04659 | Th17 cell differentiation - Homo sapiens (human) |
kegg | hsa04710 | Circadian rhythm - Homo sapiens (human) |
kegg | hsa05321 | Inflammatory bowel disease (IBD) - Homo sapiens (human) |
wikipathways | WP170 | Nuclear Receptors |
wikipathways | WP1797 | Circadian Clock |
wikipathways | WP236 | Adipogenesis |
wikipathways | WP3355 | BMAL1-CLOCK,NPAS2 activates circadian gene expression |
wikipathways | WP3893 | Development and heterogeneity of the ILC family |
wikipathways | WP3946 | White fat cell differentiation |
wikipathways | WP4066 | Interleukin-4 and 13 signaling |
wikipathways | WP4149 | White fat cell differentiation |
wikipathways | WP706 | Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways |
reactome | R-HSA-1280215 | Cytokine Signaling in Immune system |
reactome | R-HSA-1368082 | RORA activates gene expression |
reactome | R-HSA-1368082 | RORA activates gene expression |
reactome | R-HSA-1430728 | Metabolism |
reactome | R-HSA-168256 | Immune System |
reactome | R-HSA-1989781 | PPARA activates gene expression |
reactome | R-HSA-212436 | Generic Transcription Pathway |
reactome | R-HSA-2990846 | SUMOylation |
reactome | R-HSA-3108232 | SUMO E3 ligases SUMOylate target proteins |
reactome | R-HSA-383280 | Nuclear Receptor transcription pathway |
reactome | R-HSA-392499 | Metabolism of proteins |
reactome | R-HSA-400206 | Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha) |
reactome | R-HSA-400253 | Circadian Clock |
reactome | R-HSA-400253 | Circadian Clock |
reactome | R-HSA-4090294 | SUMOylation of intracellular receptors |
reactome | R-HSA-449147 | Signaling by Interleukins |
reactome | R-HSA-556833 | Metabolism of lipids |
reactome | R-HSA-597592 | Post-translational protein modification |
reactome | R-HSA-6785807 | Interleukin-4 and Interleukin-13 signaling |
reactome | R-HSA-73857 | RNA Polymerase II Transcription |
reactome | R-HSA-74160 | Gene expression (Transcription) |
Gene-Drug: Aster Plot
Drug ID | Drug Name | Model Num. |
---|---|---|
iGMDRD405 | PIK-75 | 5 |
iGMDRD79 | Gemcitabine | 4 |
iGMDRD522 | ML-030 | 2 |
iGMDRD150 | RITA | 6 |
iGMDRD532 | Olaparib | 2 |
iGMDRD219 | Bax channel blocker | 6 |
iGMDRD237 | ABT-751 | 3 |
iGMDRD698 | Neratinib | 5 |
iGMDRD314 | Tanespimycin | 5 |
iGMDRD341 | Triacsin c | 2 |
iGMDRD945 | ML214 | 5 |
iGMDRD123 | Isoevodiamine | 7 |
iGMDRD5 | Tyrphostin AG 1478 | 3 |
iGMDRD158 | NSC141540 | 2 |
iGMDRD121 | GMX1778 | 2 |
iGMDRD202 | Curcumin | 3 |
iGMDRD137 | Indisulam | 11 |
iGMDRD251 | ML162 | 3 |
iGMDRD77 | Itraconazole | 2 |
iGMDRD289 | Parthenolide | 8 |
iGMDRD329 | Merck60 | 6 |
iGMDRD286 | Nsc 632839 | 7 |
iGMDRD871 | BRD6368 | 4 |
iGMDRD367 | Ro 28-1675 | 2 |
iGMDRD420 | Leucascandrolide A | 3 |
iGMDRD433 | Lexibulin | 2 |
iGMDRD151 | CHM-1 | 5 |
iGMDRD76 | Simvastatin | 3 |
iGMDRD126 | Tipifarnib | 5 |
iGMDRD781 | Sirolimus | 10 |
iGMDRD483 | SCH-529074 | 5 |
iGMDRD427 | ABT737 | 7 |
iGMDRD61 | Kinetin riboside | 2 |
iGMDRD639 | YK 4-279 | 3 |
iGMDRD466 | Chaetocin | 1 |
iGMDRD394 | BX-795 | 1 |
iGMDRD474 | Avrainvillamide | 4 |
iGMDRD513 | BML-259 | 3 |
iGMDRD187 | BRD9876 | 7 |
iGMDRD294 | Batimastat | 2 |
iGMDRD801 | 2,4-dideoxy-DC-45-A2 | 5 |
iGMDRD171 | Pemetrexed | 6 |
iGMDRD780 | PP-30 | 5 |
iGMDRD224 | Necrostatin-1 | 6 |
iGMDRD506 | Fedratinib | 8 |
iGMDRD399 | Selumetinib | 3 |
iGMDRD730 | Kahalalide F | 2 |
iGMDRD74 | Idarubicin | 4 |
iGMDRD188 | Piperlongumine | 6 |
iGMDRD524 | ISX-9 | 6 |
iGMDRD23 | Gossypol | 2 |
iGMDRD64 | Parbendazole | 7 |
iGMDRD148 | Pifithrin-mu | 1 |
iGMDRD512 | nutlin 3 | 2 |
iGMDRD307 | Manumycin A | 2 |
iGMDRD84 | Lovastatin acid | 2 |
iGMDRD701 | NVP-AUY922 | 4 |
iGMDRD345 | Compound 10b [PMID: 11504634] | 6 |
iGMDRD424 | Tamatinib | 2 |
iGMDRD351 | GW843682X | 11 |
iGMDRD85 | Ursolic acid | 3 |
iGMDRD435 | BI-2536 | 2 |
iGMDRD177 | Teniposide | 2 |
iGMDRD901 | ELCPK | 2 |
iGMDRD267 | Oligomycin A | 3 |
iGMDRD481 | Dactolisib | 2 |
iGMDRD872 | BRD7137 | 2 |
iGMDRD882 | CIL41 | 5 |
iGMDRD414 | MST-312 | 3 |
iGMDRD353 | PD0325901 | 2 |
iGMDRD82 | Quiflapon | 3 |
iGMDRD300 | Tozasertib | 7 |
iGMDRD886 | Compound 1541A | 2 |
iGMDRD505 | Pevonedistat | 9 |
iGMDRD772 | BRD4770 | 2 |
iGMDRD599 | Salermide | 1 |
iGMDRD144 | NSC95397 | 5 |
iGMDRD193 | Fqi1 | 5 |
iGMDRD446 | LY 2183240 | 5 |
iGMDRD380 | Pifithrin-alpha | 1 |
iGMDRD634 | SCHEMBL2608041 | 3 |
iGMDRD280 | CYTOCHALASIN B | 4 |
iGMDRD802 | 4-methylfasudil | 5 |
iGMDRD255 | SB225002 | 8 |
iGMDRD138 | PX 12 | 2 |
iGMDRD298 | L-685458 | 2 |
iGMDRD870 | BRD63610 | 5 |
iGMDRD885 | Compound 110 | 9 |
iGMDRD318 | PAC-1 | 7 |
iGMDRD782 | DC-45-A2 | 2 |
iGMDRD562 | Navitoclax | 2 |
iGMDRD577 | BIX01294 | 6 |
iGMDRD100 | Zebularine | 4 |
iGMDRD451 | Serdemetan | 3 |
iGMDRD444 | Tivantinib | 2 |
iGMDRD268 | Cerulenin | 3 |
iGMDRD60 | Quinoclamine | 2 |
iGMDRD690 | PRIMA-1MET | 2 |
Gene in drug-gene network: Network Plot
Gene-drug targets distribution
Gene Structure: PDB
Models in RORA